Similar articles

• EFFECTS OF FEMALE HORMONES, USED AS ORAL CONTRACEPTIVES, ON THE FIBRINOLYTIC SYSTEM IN BLOOD.

  BRAKMAN P, ASTRUP T. BRAKMAN P, et al. Lancet. 1964 Jul 4;2(7349):10-2. doi: 10.1016/s0140-6736(64)90005-4. Lancet. 1964. PMID: 14149193 No abstract available.
• [THROMBOLYTIC THERAPY AND CHANGES IN FIBRINOLYTIC ACTIVITY].

  DOUGLAS AS, MCNICOL GP. DOUGLAS AS, et al. Recenti Prog Med. 1964 Sep;37:189-217. Recenti Prog Med. 1964. PMID: 14229145 Review. Italian. No abstract available.
• THROMBOLYTIC THERAPY.

  FLUTE PT. FLUTE PT. J Clin Pathol. 1964 May;17(3):333-5. doi: 10.1136/jcp.17.3.333. J Clin Pathol. 1964. PMID: 14159475 Free PMC article. No abstract available.
• THE PROACTIVATOR (PLASMINOGEN?) DETERMINATION IN PLASMA DURING FIBRINOLYTIC THERAPY.

  BLIX S. BLIX S. Acta Med Scand. 1964 Nov;176:649-50. doi: 10.1111/j.0954-6820.1964.tb00669.x. Acta Med Scand. 1964. PMID: 14223542 No abstract available.
• THE FIBRINOLYTIC SYSTEM IN HEALTH AND DISEASE.

  JOHNSON AJ, NEWMAN J. JOHNSON AJ, et al. Semin Hematol. 1964 Oct;1:401-31. Semin Hematol. 1964. PMID: 14225683 Review. No abstract available.